Zdrowie i gospodarka · 08/02/2022
FDA Announces Draft Guidance for Antibody-Drug Conjugates
The FDA has released a draft guidance outlining clinical pharmacology considerations for the development of antibody-drug conjugates (ADCs), addressing key areas such as bioanalytical methods, dose selection, and QTc assessments.
Source: Federal Register — Food and Drug AdministrationOpen original release →